HRAS G13D, a new mutation implicated in the resistance to anti-EGFR therapies in colorectal cancer, a case report

Int J Colorectal Dis. 2016 Jun;31(6):1245-6. doi: 10.1007/s00384-015-2448-7. Epub 2015 Nov 12.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics*
  • Drug Resistance, Neoplasm* / genetics
  • ErbB Receptors / antagonists & inhibitors*
  • ErbB Receptors / metabolism
  • Humans
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Proto-Oncogene Proteins p21(ras) / genetics*

Substances

  • ErbB Receptors
  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)